CYCN Financials
Cyclerion Therapeutics Inc - Financial statements & key metrics
Stock Price
$1.35
Market Cap
$5.14M
EPS
$-0.70
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.00M
Gross Profit
-
Operating Income
-
Net Income
$-3.06M
EPS (Diluted)
$-1.21
Balance Sheet Highlights
Total Assets
$9.57M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$3.23M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-4.33M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
92.6%
Operating Margin
-1.1%
Net Margin
-0.8%
ROE
-0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CYCN revenue?
CYCN's most recent quarterly revenue was $2.00M. Annual revenue can be calculated by summing the four most recent quarters.
Is CYCN profitable?
CYCN reported a loss of $3.06M in the most recent quarter. The net profit margin is -0.8%.
What is CYCN market cap?
CYCN has a market capitalization of $5.14M, making it a small-cap stock.
Does CYCN have debt?
View CYCN's balance sheet for debt information.
What is CYCN cash flow?
Cash flow data is available in the full financial statements.